Impact of chronic kidney disease and anemia on physical function in patients with chronic heart failure

Masakazu Saitoh1, Haruki Itoh2, Nobuo Morotomi3

  • 1Department of Physiotherapy, Sakakibara Heart Institute, Tokyo, Japan.

Cardiorenal Medicine
|September 26, 2014
PubMed

Insights

Chronic kidney disease (CKD) and anemia significantly impair physical function in heart failure patients. Their combined presence leads to a greater decline in physical performance than either condition alone.

Area of Science:

  • Nephrology
  • Cardiology
  • Geriatrics

Background:

  • Chronic heart failure (HF) patients often experience comorbidities.
  • Chronic kidney disease (CKD) and anemia are common in HF and may impact physical function.
  • The combined impact of CKD and anemia on physical function in HF is not fully understood.

Purpose of the Study:

  • To confirm the effects of CKD and anemia on physical function in HF patients.
  • To investigate the additive effect of combined CKD and anemia on physical function.

Main Methods:

  • 102 chronic HF patients were enrolled.
  • CKD defined as eGFR <60 ml/min/1.73 m²; anemia defined by hemoglobin levels.
  • Physical function assessed using the Short Physical Performance Battery (SPPB).

Main Results:

  • Patients with both CKD and anemia had significantly lower SPPB scores.
  • The reduction in physical function was more pronounced in patients with both conditions compared to those with one or neither.
  • p < 0.05 indicated statistical significance.

Conclusions:

  • CKD and anemia are independently associated with reduced physical function in HF patients.
  • The combination of CKD and anemia has an additive negative effect on physical function.
  • These findings highlight the importance of managing CKD and anemia in HF patients to improve physical performance.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
673
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
626
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
676
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K